# Samsung Bioepis

> Biopharmaceutical product development

Business model and tags: B2B, Multi-product, Pharma & life sciences, Subsidiary, International operations, Has in-house R&D, Sells through distributors

## About Samsung Bioepis

A biopharmaceutical company founded in 2012, dedicated to making healthcare accessible through innovative, high-quality biosimilar products in various therapeutic areas

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Yeonsu-gu, Incheon, South Korea
- **Founded**: 2012
- **Revenue**: KRW 104B – KRW 824B (Tamtam estimate)
- **Website**: [samsungbioepis.com](https://www.samsungbioepis.com/kr/index.do)
- **LinkedIn**: [linkedin.com/company/samsungbioepis](https://www.linkedin.com/company/samsungbioepis)

## Samsung Bioepis at a glance

Samsung Bioepis is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Yeonsu-gu, Incheon, South Korea.

Samsung Bioepis was founded in 2012.

Samsung Bioepis has 1,001–5,000 employees.

Samsung Bioepis's revenue is KRW 104B – KRW 824B (Tamtam estimate).

## Frequently asked questions about Samsung Bioepis

### What is Samsung Bioepis's revenue?

Tamtam estimates Samsung Bioepis's annual revenue at KRW 104B – KRW 824B.

### How many employees does Samsung Bioepis have?

Samsung Bioepis has 1,001–5,000 employees.

### Where is Samsung Bioepis headquartered?

Samsung Bioepis is headquartered in Yeonsu-gu, Incheon, South Korea.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/samsung-bioepis
